Dr. Zachary Slepchuk is a Holyoke native who went to high school at St. Mary’s in Westfield. He graduated from Assumption College in 2017 with honors, Cum Laude, as a biology major and attended New England College of Optometry in Boston. He completed his residency at VA Hudson Valley in New York.
Dr. Slepchuk is certified by the Board of Registration in Optometry to prescribe oral and topical therapeutic agents for the prevention, diagnosis, and treatment of glaucoma. His specialties also include Light Adjustable Lens treatment and Ocular Disease.
In his free time, Dr. Slepchuk enjoys spending time outdoors and playing sports. Some of his top hobbies are playing hockey, tennis, soccer, hiking, camping, and music.
Dr. Slepchuk is passionate about ensuring patients receive proper care, especially patients with systemic diseases that can affect the eye. It is important to Dr. Slepchuk that patients receive excellent customer service and have a good experience.
To book your next appointment with Dr. Zachary Slepchuk at our Springfield, Massachusetts office, contact Papale Eye Center today.
If you would like to schedule a cataract surgery, glaucoma, or LASIK screening with our eye surgeons, contact our Springfield, Massachusetts eye surgery center today.
If you’ve been told that you’re not a candidate for LASIK… or if you’ve been waiting for a more advanced, safe, and effective technology that may eliminate your need for glasses or contacts–the Visian ICL, otherwise known as the implantable contact lens, could be right for you. Dr. John Papale is one of the most experienced ophthalmologists in New England performing this procedure.
The Visian ICL is an Implantable Collamer Lens that works with the eye to correct vision. Unlike traditional contact lenses that go on the surface of the eye, the Visian ICL is positioned inside the eye between the iris (the colored part of the eye) and the natural lens where it stays indefinitely.
If your vision changes dramatically, however, it can be removed from the eye. There have been over 375,000 patient eyes treated worldwide with the Visian ICL.